logo

For the Inventor, By the Inventor

Manchester, United Kingdom

Renovo Limited


USPTO Granted Patents = 19

% Expired Patents = 73.7


Trademarks = 1

Forward Citations = 193

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Mark William James Ferguson (9 out of 9 patents)

silverMedal Mark W J Ferguson (9 out of 9 patents)

bronzeMedal Sharon O'Kane (5 out of 5 patents)

4.  Hugh Gerard Laverty (4 out of 4 patents)

5.  Nick Occleston (4 out of 4 patents)

6.  Phillip Mellors (3 out of 3 patents)

7.  Sally Freeman (2 out of 5 patents)

8.  Emma Atkinson (2 out of 2 patents)

9.  Georg Brunner (2 out of 2 patents)

10.  Ardeshir Bayat (1 out of 11 patents)

11.  Simon Higginbottom (1 out of 1 patent)

12.  Mark Ferguson (1 out of 1 patent)

13.  Jane Kelly (1 out of 4 patents)

14.  Wayne Burrill (1 out of 1 patent)

15.  William Ernest Royce Ollier (1 out of 1 patent)


19 patents:

1. 7947264 - TGF-β3 mutants (2011-05-24),
2. 7902150 - Medicaments and proteins based on TGF-β monomers for the treatment of wounds (2011-03-08),
3. 7893221 - Protein folding (2011-02-22),
4. 7727520 - Method of promoting the healing of a chronic wound (2010-06-01),
5. 7713933 - Pharmaceutical composition containing an activin or inhibin stimulator (2010-05-11),
6. 7700562 - Use of —furin—'convertase' inhibitors in the treatment of fibrosis and scarring (2010-04-20),
7. 7691816 - Pharmaceutical compositions (2010-04-06),
8. 7566446 - Wound healing and treatment of fibrosis (2009-07-28),
9. 7332305 - Genetic polymorphism in the Zf9 gene linked to inappropriate scarring or fibrosis (2008-02-19),
10. 7220413 - Pharmaceutical composition containing inhibitors of interferon-γ (2007-05-22),
11. 7052684 - Methods of healing wounds and fibrotic disorders using IL-10 (2006-05-30),
12. 6900181 - Pharmaceutical composition (2005-05-31),
13. 6855505 - Method for quantifying TGF-β (2005-02-15),
14. 6696433 - Use of sex steroids function modulators to treat wounds and fibrotic disorders (2004-02-24),
15. 6566339 - Pharmaceutical composition (2003-05-20),
Company Overview
Renovo Limited, based in Manchester, specializes in advanced materials and innovative solutions for various industries. The company focuses on developing cutting-edge technologies that enhance performance and sustainability in applications ranging from automotive to aerospace. With a commitment to research and development, Renovo aims to push the boundaries of material science, creating products that meet the evolving needs of its clients while contributing to a more sustainable future.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

19 Patents

#17 in Manchester

#928 in United Kingdom

#32,663 in the World

Manchester, GB
Manchester, United Kingdom

Renovo Limited

Forward Citations = 193

19 inventors:

goldMedal Mark William James Ferguson (9 out of 9 patents)

silverMedal Mark W J Ferguson (9 out of 9 patents)

bronzeMedal Sharon O'Kane (5 out of 5 patents)

4.  Hugh Gerard Laverty (4 out of 4 patents)

5.  Nick Occleston (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Renovo Limited. Retrieved from https://idiyas.com/company/renovo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…